A molecular morphometric approach to diabetic kidney disease can link structure to function and outcome.

Diabetic kidney disease is the leading cause of kidney failure. However, studies of molecular mechanisms of early kidney damage are lacking. Here we examined for possible linkage between transcriptional regulation and quantitative structural damage in early diabetic kidney disease in Pima Indians with type 2 diabetes. Tissue obtained from protocol kidney biopsies underwent genome-wide compartment-specific gene expression profiling and quantitative morphometric analysis. The ultrastructural lesion most strongly associated with transcriptional regulation was cortical interstitial fractional volume (VvInt), an index of tubule-interstitial damage. Transcriptional co-expression network analysis identified 1843 transcripts that correlated significantly with VvInt. These transcripts were enriched for pathways associated with mitochondrial dysfunction, inflammation, migratory mechanisms, and tubular metabolic functions. Pathway network analysis identified IL-1β as a key upstream regulator of the inflammatory response and five transcription factors cooperating with p53 to regulate metabolic functions. VvInt-associated transcripts showed significant correlation with the urine albumin to creatinine ratio and measured glomerular filtration rate 10 years after biopsy, establishing a link between the early molecular events and long-term disease progression. Thus, molecular mechanisms active early in diabetic kidney disease were revealed by correlating intrarenal transcripts with quantitative morphometry and long-term outcomes. This provides a starting point for identification of urgently needed therapeutic targets and non-invasive biomarkers of early diabetic kidney disease.

[1]  K. Shedden,et al.  NFkappaB promotes inflammation, coagulation, and fibrosis in the aging glomerulus. , 2010, Journal of the American Society of Nephrology : JASN.

[2]  Benjamin J. Keller,et al.  Integrative biology identifies shared transcriptional networks in CKD. , 2014, Journal of the American Society of Nephrology : JASN.

[3]  T. Meyer,et al.  Evolution of incipient nephropathy in type 2 diabetes mellitus. , 2000, Kidney international.

[4]  P. Bennett,et al.  Glomerular permselectivity at the onset of nephropathy in type 2 diabetes mellitus. , 2000, Journal of the American Society of Nephrology : JASN.

[5]  C. Cohen,et al.  Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application. , 2002, Kidney international.

[6]  R. Hanson,et al.  Predictive power of sequential measures of albuminuria for progression to ESRD or death in Pima Indians with type 2 diabetes. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  T. Weinstein,et al.  Glomerular hemodynamics in severe obesity. , 2000, American journal of physiology. Renal physiology.

[8]  Felix Eichinger,et al.  Modular Activation of Nuclear Factor-κB Transcriptional Programs in Human Diabetic Nephropathy , 2006, Diabetes.

[9]  J. Patel,et al.  Identification of Cross-Species Shared Transcriptional Networks of Diabetic Nephropathy in Human and Mouse Glomeruli , 2012, Diabetes.

[10]  Quan Dong Nguyen,et al.  Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. , 2003, JAMA.

[11]  M. Rastaldi,et al.  Enhanced Expression of Janus Kinase–Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy , 2009, Diabetes.

[12]  Andreas Krämer,et al.  Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..

[13]  R. Schmieder,et al.  How should renal hemodynamic data be indexed in obesity? , 1995, Journal of the American Society of Nephrology.

[14]  K. Suszták,et al.  Transcriptome Analysis of Human Diabetic Kidney Disease , 2011, Diabetes.

[15]  B. Kasiske,et al.  Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  R. Hanson,et al.  Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes , 2013, Diabetes.

[17]  Haifeng Guo,et al.  US Renal Data System 2012 Annual Data Report. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  B. Zinman,et al.  Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. , 2011, Archives of internal medicine.

[19]  M. Woodward,et al.  Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis , 2012, The Lancet.

[20]  R. Radermecker,et al.  Indexing glomerular filtration rate for body surface area in obese patients is misleading: concept and example. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  R. Bader,et al.  Structure and function of the kidney in diabetic glomerulosclerosis. Correlations between morphological and functional parameters. , 1980, Pathology, research and practice.

[22]  E. Weibel Practical methods for biological morphometry , 1979 .

[23]  Jun Wada,et al.  Innate immunity in diabetes and diabetic nephropathy , 2016, Nature Reviews Nephrology.

[24]  Andrzej S Krolewski,et al.  Regression of microalbuminuria in type 1 diabetes. , 2003, The New England journal of medicine.

[25]  Jinu Kim,et al.  Targeted deletion of p53 in the proximal tubule prevents ischemic renal injury. , 2014, Journal of the American Society of Nephrology : JASN.

[26]  Alan B Leichtman,et al.  US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  Patrick J Heagerty,et al.  Temporal trends in the prevalence of diabetic kidney disease in the United States. , 2011, JAMA.

[28]  A Bohle,et al.  The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis. , 1991, Pathology, research and practice.

[29]  Merlin C. Thomas,et al.  The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes , 2009, Diabetes.

[30]  P. Bennett,et al.  Change in the Distribution of Albuminuria According to Estimated Glomerular Filtration Rate in Pima Indians With Type 2 Diabetes , 2009, Diabetes Care.

[31]  H. Anders Of Inflammasomes and Alarmins: IL-1β and IL-1α in Kidney Disease. , 2016, Journal of the American Society of Nephrology : JASN.

[32]  H. Anders,et al.  Canonical and non-canonical effects of the NLRP3 inflammasome in kidney inflammation and fibrosis. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[33]  R. Olshen,et al.  Modeling GFR trajectories in diabetic nephropathy. , 2005, American journal of physiology. Renal physiology.

[34]  R. G. Miller,et al.  In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study , 2010, Diabetologia.

[35]  A. Sanz,et al.  Suppressors of cytokine signaling abrogate diabetic nephropathy. , 2010, Journal of the American Society of Nephrology : JASN.

[36]  Steve Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[37]  K. Shedden,et al.  Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker , 2015, Science Translational Medicine.

[38]  J. Bonventre Can we target tubular damage to prevent renal function decline in diabetes? , 2012, Seminars in nephrology.

[39]  Ping Zhang,et al.  The Lifetime Cost of Diabetes and Its Implications for Diabetes Prevention , 2014, Diabetes Care.

[40]  W. Neuhofer Role of NFAT5 in Inflammatory Disorders Associated with Osmotic Stress , 2010, Current genomics.

[41]  M. Kretzler,et al.  JAK inhibition in the treatment of diabetic kidney disease , 2016, Diabetologia.

[42]  R. Nelson,et al.  Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy , 2012, Kidney international.

[43]  K. Nath,et al.  Tubulointerstitial changes as a major determinant in the progression of renal damage. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[44]  A. Levey,et al.  Obesity, glomerular hyperfiltration, and the surface area correction. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[45]  J. Navarro-González,et al.  Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy , 2011, Nature Reviews Nephrology.